• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.

作者信息

Wein Alan J

出版信息

J Urol. 2018 Nov;200(5):950-951. doi: 10.1016/j.juro.2018.08.033. Epub 2018 Aug 17.

DOI:10.1016/j.juro.2018.08.033
PMID:30360351
Abstract
摘要

相似文献

1
Re: Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.关于“压力性尿失禁控制、疗效与安全性研究”的十二个月疗效和安全性数据：一项使用Vesair膀胱内球囊治疗女性压力性尿失禁的III期、多中心、前瞻性、随机、对照研究
J Urol. 2018 Nov;200(5):950-951. doi: 10.1016/j.juro.2018.08.033. Epub 2018 Aug 17.
2
Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.“压力性尿失禁控制、疗效与安全性研究”的12个月疗效与安全性数据：一项使用Vesair膀胱内球囊治疗女性压力性尿失禁的III期多中心前瞻性随机对照研究
Female Pelvic Med Reconstr Surg. 2018 May/Jun;24(3):222-231. doi: 10.1097/SPV.0000000000000488.
3
Re: Three-Month Primary Efficacy Data for the SUCCESS Trial; a Phase III, Multi-Center, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence with the Vesair Intravesical Balloon.
J Urol. 2019 May;201(5):864. doi: 10.1097/01.JU.0000554114.24744.c0.
4
Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon.SUCCESS试验的三个月主要疗效数据；一项III期、多中心、前瞻性、随机对照研究，使用Vesair膀胱内球囊治疗女性压力性尿失禁。
Neurourol Urodyn. 2018 Jan;37(1):440-448. doi: 10.1002/nau.23324. Epub 2017 Nov 2.
5
Minimal Device Encrustation on Vesair Intravesical Balloons in the Treatment of Stress Urinary Incontinence: Analysis of Balloons Removed from Women in the SOLECT Trial.Vesair膀胱内球囊治疗压力性尿失禁时的最低限度装置结痂：SOLECT试验中从女性体内取出球囊的分析
Adv Ther. 2017 Jul;34(7):1686-1694. doi: 10.1007/s12325-017-0570-3. Epub 2017 Jun 9.
6
A randomized, controlled clinical trial of an intravesical pressure-attenuation balloon system for the treatment of stress urinary incontinence in females.一项用于治疗女性压力性尿失禁的膀胱内压力衰减球囊系统的随机对照临床试验。
Neurourol Urodyn. 2016 Feb;35(2):252-9. doi: 10.1002/nau.22708. Epub 2015 Jan 16.
7
A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence.一种新型膀胱内压力衰减装置治疗压力性尿失禁的随机对照临床试验。
J Urol. 2013 Dec;190(6):2243-50. doi: 10.1016/j.juro.2013.06.042. Epub 2013 Jun 21.
8
Re: A Randomized Controlled Clinical Trial of an Intravesical Pressure Attenuation Balloon System for the Treatment of Stress Urinary Incontinence in Females.回复：一项关于膀胱内压力衰减球囊系统治疗女性压力性尿失禁的随机对照临床试验
J Urol. 2016 Oct;196(4):1213-4. doi: 10.1016/j.juro.2016.07.036. Epub 2016 Jul 15.
9
Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study.聚丙稀酰胺水凝胶治疗女性压力性尿失禁的有效性和安全性：一项随机、前瞻性、多中心北美研究。
J Urol. 2014 Sep;192(3):843-9. doi: 10.1016/j.juro.2014.03.109. Epub 2014 Apr 2.
10
Involuntary reflexive pelvic floor muscle training in addition to standard training versus standard training alone for women with stress urinary incontinence: study protocol for a randomized controlled trial.压力性尿失禁女性患者在标准训练基础上增加非自主反射性盆底肌训练与单纯标准训练比较的随机对照试验研究方案。
Trials. 2015 Nov 17;16:524. doi: 10.1186/s13063-015-1051-0.